Ameriprise
ZYME icon

Ameriprise’s Zymeworks ZYME Stock Holding History

Ameriprise’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Buy
82,264
+8,042
+11% +$204K ﹤0.01% 3039
2026
Q1 		$1.86M Sell
74,222
-38,919
-34% -$921K ﹤0.01% 2996
2025
Q4 		$2.98M Buy
113,141
+37,213
+49% +$812K ﹤0.01% 2784
2025
Q3 		$1.3M Buy
+75,928
New +$1.09M ﹤0.01% 3232
2025
Q1 		– Sell
-121,526
Closed -$1.78M – 4164
2024
Q4 		$1.78M Sell
121,526
-15,800
-12% -$221K ﹤0.01% 2990
2024
Q3 		$1.72M Hold
137,326
– – ﹤0.01% 2987
2024
Q2 		$1.17M Sell
137,326
-4,467
-3% -$39.8K ﹤0.01% 3097
2024
Q1 		$1.49M Buy
141,793
+18,867
+15% +$210K ﹤0.01% 3008
2023
Q4 		$1.28M Buy
+122,926
New +$980K ﹤0.01% 3091

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Ameriprise's ZYME Position: Q2 2026 in Review

Ameriprise increased its Zymeworks (ZYME) stake by 11% in Q2 2026, buying an estimated $204K and bringing the position to 82,264 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3039.

Ameriprise first reported a position in ZYME in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.98M in Q4 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Ameriprise held 82,264 shares of Zymeworks worth $2.15M as of Q2 2026.
  • Ameriprise bought 8,042 Zymeworks shares in Q2 2026, an estimated $204K.
  • Zymeworks made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3039 holding.
  • Ameriprise first reported a position in Zymeworks in Q4 2023 and has held it in 9 quarters since.
  • Ameriprise's Zymeworks position peaked at $2.98M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.